- HECT ubiquitin ligases are a specialised family of E3 enzymes distinguished by their ability to form a covalent thioester intermediate with ubiquitin before transferring it to substrate proteins. This mechanism sets them apart from RING‑type ligases, which act as scaffolds, and places HECT ligases at the centre of highly regulated ubiquitin‑signalling pathways. The defining feature of HECT ligases is the HECT domain, located at the C‑terminus, which accepts ubiquitin from an E2 conjugating enzyme and catalyses its direct attachment to the substrate. This catalytic relay gives HECT ligases precise control over ubiquitin‑chain architecture, including the ability to specify K48‑linked or K63‑linked chains depending on the ligase and cellular context.
- HECT ligases are divided into three major subfamilies: NEDD4‑family ligases, HERC ligases, and other HECT ligases such as HUWE1. NEDD4‑family ligases, including NEDD4, NEDD4L and ITCH, contain WW domains that recognise PY motifs on substrates, enabling selective ubiquitination of membrane receptors, ion channels and signalling proteins. These ligases regulate processes such as receptor endocytosis, viral budding and T‑cell signalling. HERC ligases, characterised by RCC1‑like domains, participate in DNA‑damage responses, vesicular trafficking and cytoskeletal organisation. HUWE1, one of the largest HECT ligases, controls apoptosis, DNA repair and mitochondrial dynamics by ubiquitinating key regulators including MCL‑1 and p53.
- Mechanistically, HECT ligases exert fine control over ubiquitin‑chain topology. Some, such as NEDD4L, preferentially assemble K63‑linked chains, promoting non‑degradative signalling, while others generate K48‑linked chains that target substrates for proteasomal degradation. This versatility allows HECT ligases to regulate diverse pathways ranging from endocytosis and membrane trafficking to DNA‑damage signalling and cell‑cycle progression. Because HECT ligases directly catalyse chain elongation, mutations in the HECT domain often disrupt chain specificity, leading to pathological signalling outcomes.
- HECT ligases are increasingly recognised for their roles in human disease. Dysregulation of NEDD4‑family ligases contributes to cancer progression, neurodegeneration and viral infection. Mutations in HERC2 and HERC1 are linked to neurodevelopmental disorders, while HUWE1 variants are associated with intellectual disability and impaired DNA‑repair capacity. Their central role in ubiquitin signalling makes HECT ligases attractive therapeutic targets, with ongoing research exploring inhibitors that modulate their catalytic activity or substrate recognition.
- Overall, HECT ubiquitin ligases represent a mechanistically unique and biologically versatile class of E3 enzymes. Their ability to directly build ubiquitin chains gives them unparalleled control over protein fate, signalling dynamics and cellular homeostasis. Understanding HECT ligases provides deep insight into ubiquitin‑mediated regulation and the molecular basis of numerous human diseases.
2 thoughts on “HECT Ubiquitin Ligase”